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Young femaleAbstract Background: Glycogen storage disease type I (GSD I) is a rare inherited metabolic dis-
order caused by deficient glucose-6-phosphatase (G6Pase) activity with a tendency to develop hypo-
glycaemia with secondary metabolic derangements including hyperlactacidemia, hyperlipidemia
and hyperuricemia.
Case presentation: We hereby report a rare case of a 23 year old female presenting with features of
gouty arthritis attributed to be due to GSD I. The patient was admitted to the General Medicine
Department, North Eastern Indira Gandhi Regional Institute of Health andMedical Sciences Hospi-
tal, Shillong,Meghalaya. The duration of arthritis was 3 years.Abdominal ultrasonography showed an
enlarged liver measuring 20.64 cm with increased echo texture. Intravenous pyelogram showed multi-
ple renal calculi on both kidneys. Fine needle aspiration cytology (FNAC) from the right metatar-
sophalangeal joint swelling showed abundant needle shaped birefringent crystals. With suspicion
of a metabolic abnormality a liver biopsy was performed which showed a picture consistent with
GSD. A glucagon stimulation (tolerance) test was performed raising the suggestion of a GSD.
Conclusion: Primary gout is relatively rare among young females so secondary gout may be
possible and the search for primary underlying disease should be pursued. Furthermore atypical pre-
sentations of GSD-1 without apparent hypoglycaemia should also be borne in mind. A high index of
264 T. Ete et al.clinical suspicion while approaching unusual cases of gouty arthritis may be the only clue for
resolution of diagnostic dilemma in such cases and establishment of a proper diagnosis and treatment.
 2015 The Authors. Publishing services provided by Elsevier B.V. on behalf of Egyptian Society of
Rheumatic Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Glycogen storage disease type I (GSD I) is a group of rare
inherited diseases resulting from a defect in the glucose-6-
phosphatase (G6Pase) system which has a key role in glucose
homoeostases as it is required for the hydrolysis of glucose-
6-phosphate (G6P) into glucose and inorganic phosphate
(Pi). The main diagnostic criteria are: hepatomegaly, fast-
induced hypoglycaemia with hyperlactacidemia, and hyper-
lipidemia [1,2]. Two main subtypes are unambiguously
recognised: GSD type Ia (GSD Ia) due to a defect of the cat-
alytic unit G6Pase alpha (or G6PC), and GSD type Ib (GSD
Ib) due to a defect of the glucose-6-phosphate translocase (or
G6PT) [2]. The manifestations of GSD Ia are usually so promi-
nent in childhood that it is readily diagnosed by paediatricians.
However, a mild form of the disease may only become appar-
ent during adolescence or adulthood [3]. Type I GSD is fre-
quently complicated by renal stone disease with urate stones
considered as the most common [4] and could manifest as gout
and myopathy [5]. A considerable number of GSD patients,
after a period of ‘silent’ hyperfiltration, renal damage develops
with proteinuria, hypertension and renal dysfunction later on
[6]. Hyperuricemia is a well-known consequence of G6Pase
deficiency, the enzymatic abnormality that characterises GSD
Ia. However, acute gout as the presenting manifestation of
GSD Ia has been reported in only a few patients [7]. Gout,
anaemia, and hepatomegaly have been recently reported in a
young man with GSD from Singapore [8].
Gout, which is characterised by deposition of monosodium
urate monohydrate (MSU) in synovial fluid and other tissues,
is the most common form of inflammatory arthritis [9]. Gouty
arthritis initially is triggered by the deposition of MSU crystals
into the joint space. This causes an inflammatory cascade
resulting in the secretion of proinflammatory cytokines and
neutrophil recruitment into the joint [10]. The presence of
MSU crystals in a symptomatic joint/bursa or in a tophus is
a gold standard for classification of the subject as having gout.
Difficulty with aspiration of small and/or examination of the
sample under polarising microscopy made it important to
implement new classification criteria including clinical (pattern
of joint/bursa involvement, characteristics and time course of
symptomatic episodes), laboratory (serum urate, MSU-
negative synovial fluid aspirate) and imaging (double-contour
sign on ultrasound or urate on dual-energy CT, radiographic
gout-related erosion) [9]. Subclinical gouty arthritis was found
by musculoskeletal ultrasonography even in those patients
with asymptomatic hyperuricemia [11]. Moreover, acute gouty
olecranon bursitis has been reported in normouricemic sub-
jects [12].
Gout is considered the most common cause of arthritis in
the elderly, due to an increase in risk factors as renal diseases,
metabolic syndrome and rich purine diets [13]. The severity of
gouty arthritis is closely related to metabolic syndrome and
insulin resistance [14]. We hereby report a rare case of a23 year old female presenting with features of gouty arthritis
attributed to be due to GSD I.
2. Case report
A 23 year old female weighing 41 kg with a height of 146 cm
(BMI 19.25 kg/m2) was admitted to the General Medicine
Department, North Eastern Indira Gandhi Regional Institute
of Health and Medical Sciences Hospital, Shillong, Meghalaya
with complaints of pain and swelling of small joints of both
upper and lower limbs for 3 years. The arthritis was associated
with fever. There was no skin rash, oral ulcers or history of
early morning stiffness. There was a history of repeated visits
to different hospitals due to intermittent attacks of arthritis
which were managed conservatively without establishment of
a definite aetiology. Only prior relevant medical history was
that of a liver disease in childhood the documentation of which
was unavailable. The case report was managed in accordance
to the hospitals local ethics committee and consent was pro-
vided by the patient.
On examination her higher mental function was normal and
her vitals were stable. No significant abnormality was detected
in her general physical examination. Systemic examination of
the abdomen was free except for palpable liver 5 fingers below
costal margin, soft in consistency with well defined margins
and absence of any rub or bruit. Musculoskeletal examination
revealed bilaterally swollen and deformed metatarsopha-
langeal joints (Fig. 1).
On investigation, she had haemoglobin (Hb) of 10.3 g/dl,
total leucocytic count (TLC) was 9400/mm3, platelet count
of 420,000/mm3, and erythrocyte sedimentation rate (ESR)
65 mm/1st h. Renal functions were normal with a serum urea
of 21 mg/dl and serum creatinine of 0.6 mg/dl. Liver function
test revealed no abnormality. Serum uric acid (SUA) was high
at 11.1 mg/dl. Lipid profile revealed serum cholesterol of
164 mg/dl, triglyceride of 703 mg/dl, high density lipoprotein
(HDL) of 32 mg/dl and low density lipoprotein (LDL) of
93 mg/dl. Her viral serology was negative for hepatitis B virus
surface antigen, anti hepatitis C virus and human immunode-
ficiency virus (HIV 1 and 2). Routine urine examination and
coagulation profile were within normal limits. The 24 h urinary
uric acid excretion was 4302 mg/24 h. Bone marrow examina-
tion, haemoglobin electrophoresis and serum protein elec-
trophoresis showed no abnormality.
Abdominal ultrasonography showed an enlarged liver mea-
suring 20.64 cm with increased echo texture. Intravenous pyel-
ogram showed multiple renal calculi on both kidneys (Fig. 2).
Echocardiography revealed structurally normal heart with nor-
mal left ventricular function.
Fine needle aspiration cytology (FNAC) from the right
metatarsophalangeal joint swelling showed abundant needle
shaped birefringent crystals (Fig. 3).
With suspicion of a metabolic abnormality a liver biopsy
was performed which revealed maintenance of architect with
Figure 1 Bilaterally swollen and deformed metatarsophalangeal joints with a large tophus on dorsum of first MTP.
Figure 2 Intravenous pyelogram showing multiple renal calculi in
both kidneys.
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lar red cytoplasmic granules and microvesicular with
macrovesicular steatosis. Also seen were multiple glycogenated
nuclei. There was mild sprinkling of chronic inflammatory cells
in the portal area and subtly by the lobules. Periodic acid–
Schiff (PAS) staining for glycogen was positive. PAS staining
with diastase was sensitive. There was no increase in fibrosis/
collagen in reticulin and masson’s trichrome staining (Fig. 4).
Liver biopsy findings were suggestive of glycogen storage
disease.For confirmation a glucagon stimulation (tolerance) test
was performed which revealed less than normal increase in
the level of blood glucose level even after administration of
glucagon highly suggestive of a glycogen storage disease
(GSD). A quantitative enzyme assay could not be done due
to resource constraints. A final diagnosis of a 23 year old
female with glycogen storage disease type I presenting with
chronic gouty arthritis and renal calculus was made.
3. Discussion
Hyperuricemia and gout occur commonly in cases of GSD I. A
decreased renal excretion of urate secondary to lactic academia
and ketonaemia and an elevated production of uric acid
account for hyperuricemia [15]. The mechanisms for increased
urate synthesis have been related to the hypoglycaemia, which
is a central feature of G6Pase deficiency. As hypoglycaemia
stimulates the secretion of glucagon, glucagon activates glyco-
gen phosphorylase and the formation of phosphorylated sug-
ars accentuated by the G6Pase deficiency, and the
phosphorylation of sugars utilises adenosine triphosphate
(ATP) which is degraded to uric acid [15,16].
Clinically, gout has often been considered to be a preferen-
tially male disease. The impact of female hormones cannot be
neglected because oestradiol can lower serum urate in females,
and the serum urate rises after the menopause [17,18]. Indeed
the difference in age between men and women at the onset of
gout is remarkable. One of the reasons is possibly the meno-
pause. After the menopause, the incidence of gout is high com-
pared to the reproductive age. Our case demonstrates an
unusual occurrence of gout secondary to GSD-1 in a young
female. The lack of clinical suspicion of existence of gout in
females secondary to disorders of metabolism of glycogen
can lead to frequent misdiagnosis and lack of appropriate
therapy.
A point of interest in our case is the absence of hypogly-
caemia as a presenting feature. Generally one of the cardinal
Figure 3 Fine needle aspiration biopsy (FNAC) from the right metatarsophalangeal joint swelling which showed abundant needle shaped
birefringent crystals in polarised microscopy.
Figure 4 Liver biopsy: hepatocytes appeared swollen with granular red cytoplasmic granules, micro and macrovesicular steatosis with
multiple glycogenated nuclei. PAS staining for glycogen was positive. PAS staining with diastase was sensitive. There was no increase in
fibrosis/collagen in reticulin and masson’s trichrome staining.
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sodes. A possible mechanism of this may be the role of G6Pase
in the small intestine in the control of glucose homoeostases
which has been well established. Gluconeogenesis in the small
intestine plays an important role in glucose balance. These
data have been confirmed in the liver-specific G6Pase gene
knock-out mice who do not exhibit hypoglycaemia due to their
intestinal (and renal) G6Pase activity [19,20].The diagnosis of GSD-1 is primarily entailed in the char-
acteristic clinical features along with the use of challenge
tests like the glucagon challenge test. Demonstration of
quantitative enzyme activity can be coupled to make the
diagnosis more accurate which however was not possible
in our case.
In conclusion, primary gout is relatively rare among young
females so secondary gout may be possible and the search for
Glycogen storage disease type 1a presenting as gouty arthritis 267primary underlying disease should be pursued. Furthermore
atypical presentations of GSD-1 without apparent hypogly-
caemia should also be borne in mind. A high index of clinical
suspicion while approaching unusual cases of gouty arthritis
may be the only clue for resolution of diagnostic dilemma in
such cases and establishment of a proper diagnosis and
treatment.
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